Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 33.3%GRADE not reported 0 · 0%Very low 2 · 33.3%Low 1 · 16.7%Moderate 1 · 16.7%High 0 · 0%

Summary of findings table ‐ Convalescent plasma vs standard plasma

Serious adverse events · individuals with moderate to severe disease

It is very uncertain whether summary of findings table ‐ Convalescent plasma changes serious adverse events compared with standard plasma (very low certainty).

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
RR 0.8 [0.55, 1.15]
3 studies · 327 participants
Very low

Summary of findings table ‐ Convalescent plasma vs standard plasma

Grades 3 and 4 adverse events · individuals with moderate to severe disease

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 248 participants
Very low

Summary of findings table ‐ Convalescent plasma vs placebo or usual care

Grades 3 and 4 adverse events · individuals with moderate to severe disease

Summary of findings table ‐ Convalescent plasma showed no clear difference in grades 3 and 4 adverse events compared with placebo or standard care alone (low certainty).

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
RR 1.17 [0.96, 1.42]
6 studies · 2392 participants
Low

Summary of findings table ‐ Convalescent plasma vs placebo or usual care

Serious adverse events ‐ total · individuals with moderate to severe disease

Summary of findings table ‐ Convalescent plasma showed no clear difference in serious adverse events ‐ total compared with placebo or standard care alone (moderate certainty).

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
RR 1.14 [0.91, 1.44]
6 studies · 3901 participants
Moderate

Summary of findings table ‐ Convalescent plasma vs human immunoglobulin

Serious adverse events ‐ not reported · individuals with moderate to severe disease

The review found no eligible studies for this question.

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Convalescent plasma vs human immunoglobulin

Grades 3 and 4 adverse events ‐ not reported · individuals with moderate to severe disease

The review found no eligible studies for this question.

1 finding from 1 review

Convalescent plasma for people with COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found